Last reviewed · How we verify

NCT03752645

Subjects With Clinical Diagnosis of Allergic Rhinitis Were Randomly Divided Into 2 Groups, With Patients in One Group Given One Treatment Session of Red Light Rhinophototherapy, Followed by Medical Treatment. Those in the Second Group Were Treated With Medical Treatment Only.

Completed NA Last updated 26 November 2018
What this trial tests

NA trial testing Transverse Many Channels Laser Instrument in Allergic Rhinitis in 60 participants. Completed in 30 June 2018.

Timeline
2 March 2018
Primary endpoint
27 June 2018
30 June 2018

Quick facts

Lead sponsorTaichung Veterans General Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment60
Start date2 March 2018
Primary completion27 June 2018
Estimated completion30 June 2018
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taichung Veterans General Hospital

Who can join

20 and older, any sex, with Allergic Rhinitis or Phototherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the short-term effects of red light rhinophototherapy on nasal patency in patients with a clinical diagnosis of allergic rhinitis using both active anterior rhinomanometry and acoustic rhinometry.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Red Light Rhinophototherapy on Nasal Patency in Patients with Allergic Rhinitis.
    Jiang RS, Wang JJ. · · 2018 · cited 2× · PMID 30647740 · DOI 10.1155/2018/6270614

Verify or expand the search:

Other recruiting trials for Allergic Rhinitis

Currently open trials in the same condition.

Other Taichung Veterans General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03752645.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing